Bioceres Crop Solutions Corp Stock Price, News & Analysis

Bioceres Crop Solutions (NASDAQ: BIOX), a company specializing in agricultural productivity solutions and ecosystem regeneration, has scheduled its fiscal third quarter 2025 financial results conference call for Wednesday, May 21, 2025, at 8:30 a.m. ET. The company will release its financial results for the quarter ended March 31, 2025, before the call.

The conference call will feature key executives including CEO Federico Trucco, CFO Enrique Lopez Lecube, CCO Milen Marinov, and Head of IR Paula Savanti. A presentation will accompany the webcast, accessible through the company's investor relations website. The call replay will be available until June 4, 2025.

Bioceres Crop Solutions (NASDAQ: BIOX) has received EPA federal registration for Rinotec, its innovative insecticide and nematicide platform. The product, which is exempt from residue tolerance requirements due to its negligible risk to human health and non-target organisms, has already secured approval for commercialization in Brazil.

The Rinotec platform features a unique metabolite-based approach to biologicals that enables significant dose reductions while maintaining the efficiency of synthetic chemical pesticides. This makes it suitable for both row and specialty crops. With registrations in both the U.S. and Brazilian markets, BIOX is now positioned to advance its regulatory and commercial strategies in two of the world's largest agricultural economies.

Bioceres Crop Solutions (NASDAQ: BIOX) has received a Notice of Allowance from the USPTO for its first event-specific patent covering HB4 Wheat, securing protection until 2042. This is the first of four potential patents for HB4 Wheat in the United States.

HB4 wheat technology offers improved drought tolerance and enhanced weed management compared to conventional wheat. The technology has already received USDA approval for cultivation and FDA approval for food and feed use in the U.S., which is the fourth largest wheat producer with nearly 40 million acres harvested in the most recent marketing year.

The company will follow the U.S. Wheat Associates' biotechnology commercialization principles, including securing regulatory approvals in major export markets, establishing tolerance thresholds, providing trait detection tests, and implementing product stewardship. The commercial rollout will utilize a broad licensing approach.

Bioceres Crop Solutions (NASDAQ: BIOX) reported fiscal Q2 2025 results with total revenues of $106.7 million, down 24% from $140.2 million in Q2 2024. The company posted net income of $0.6 million and Adjusted EBITDA of $15.4 million.

The revenue decline was primarily attributed to challenging conditions in Argentina, including tight farm economics and elevated channel inventories, which affected crop protection and specialty fertilizers markets. Despite market contraction, the company maintained market share in key product segments.

The company announced strategic changes, including appointing Milen Marinov as Chief Commercial Officer and exiting breeding and seed production activities to focus on trait development. New partnerships include an alliance with GDM for soybean solutions and a redefined scope with Florimond Desprez for wheat technology.

Gross profit was $45.1 million, with margin improving to 42% from 37% year-over-year, driven by an improved product mix in core segments.

Bioceres Crop Solutions (NASDAQ: BIOX) has released preliminary financial expectations for Q2 FY2025, ending December 31, 2024. The company anticipates revenues of approximately $105 million, gross profit of $45 million, and adjusted EBITDA of $15 million.

The results reflect challenging conditions in Argentina, a key market for the company's first-half performance. Farmer purchasing behavior has significantly changed due to macroeconomic conditions and unfavorable weather, leading to lower sales in crop protection and micro-beaded fertilizers. High channel inventories have also impacted performance.

CEO Federico Trucco acknowledged the industry-wide challenges but expressed confidence in the company's product portfolio and global delivery capabilities. The company will provide detailed results in its earnings release on February 11, 2025.

Bioceres Crop Solutions (NASDAQ: BIOX) has scheduled its fiscal second quarter 2025 financial results conference call for Wednesday, February 12, 2025, at 8:30 a.m. Eastern Time. The company will release detailed financial results for the quarter ended December 31, 2024, before the call.

The conference call will feature presentations from CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of IR Paula Savanti, followed by a Q&A session. A presentation will accompany the webcast and will be accessible through the company's investor relations website.

The call will be available for replay until February 19, 2025, through both the company's website and dedicated replay phone numbers.

Bioceres Crop Solutions (NASDAQ: BIOX) reported fiscal Q1 2025 results with total revenues of $93.3 million, down 20% from $116.6 million in Q1 2024. The company posted a net loss of $5.3 million and Adjusted EBITDA of $8.5 million. Performance was impacted by slow summer crop season in Argentina due to delayed rains, though partially offset by growth in North America and Brazil. Gross profit declined 17% to $37.5 million, while gross margin improved to 40.2%. The company secured regulatory approvals for HB4 soybean production in Uruguay and Bolivia, and its RinoTec technology received EPA's Green Chemistry Challenge Award.

Bioceres Crop Solutions (NASDAQ: BIOX), a company focused on agricultural ecosystem regeneration and climate-resilient crop solutions, announces its fiscal first quarter 2025 earnings conference call. The call is scheduled for Tuesday, November 12, 2024, at 8:30 a.m. Eastern Time. The company will release detailed financial results for the quarter ended September 30, 2024, before the call. The presentation will be hosted by CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of IR Paula Savanti, followed by a Q&A session. A replay will be available through November 19, 2024.